Am J Transplant, Volume 20, Suppl 3 Archives - Page 32 of 223 - ATC Abstracts

2020 American Transplant Congress
Therapeutic Inhibition of Spleen Tyrosine Kinase Decreases Hepatic Damage after Ischemia Reperfusion Injury
A. Zarrinpar, V. Boominathan, A. Kobayashi, S. Duarte
Surgery, University of Florida, Gainesville, FL
*Purpose: Hepatic ischemia/reperfusion injury (IRI) is a major challenge in transplantation. The complex array of interrelated signaling events in IRI have been studied individually, but…
2020 American Transplant Congress
Protective Effect of Fucoidan Against Tacrolimus-Induced Nephrotoxicity in LLC-PK1 Cells
H. J. Jang
Surgery, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea, Republic of
*Purpose: Tacrolimus (FK506) is an immunosuppressant agent that is frequently used to prevent rejection of solid organs upon transplant. However, nephrotoxicity due to apoptosis and…
2020 American Transplant Congress
Enhanced Recovery after Surgery Reduces Length of Hospital Stay in Renal Transplant Recipients
S. O'Neill, T. Brown, J. McCaughan, A. Courtney
Department of Transplantation, Belfast City Hospital, Belfast, United Kingdom
*Purpose: Enhanced recovery after surgery (ERAS) is an established multimodal approach to perioperative care. However, ERAS in renal transplantation isn’t common practice. ERAS involving early…
2020 American Transplant Congress
Elucidating the Genetic Background of End Stage Renal Disease of Unknown Aetiology in Patients Listed for Kidney Transplantation
E. Leenen¹, B. Beck², A. Joerres¹, A. Weidemann¹
¹Department of Medicine I - Nephrology, Transplantation & Medical Intensive Care, Medical Center Cologne-Merheim, Cologne, Germany, ²Institute of Human Genetics University Hospital Cologne, Medical Center Cologne-Merheim, Cologne, Germany
*Purpose: The prevalence of end stage renal disease (ESRD) of unknown aetiology in adult patients accounts for almost 20% of all dialysis patients in Europe.…
2020 American Transplant Congress
Pre-Transplant Sarcopenia is Associated with Increased Post-Transplant Mortality
A. Gupta¹, T. Norris², R. Montgomery¹, S. Chakraborty¹, T. Thomas¹, D. Cibrik¹, J. Klein¹, M. Gupta¹, N. Herrera¹, T. Schmitt¹, A. Nawabi¹, J. Mahnken¹
¹University of Kansas Medical Center, Kansas City, KS, ²University of Kansas School of Medicine, Kansas City, KS
*Purpose: Muscle wasting and sarcopenia in kidney disease is associated with increased cardiovascular events, morbidity and mortality. Psoas muscle cross-sectional area measured on a CT…
2020 American Transplant Congress
Risk Factors and Treatment of Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation
G. Chen, C. Wang, Z. Wu, X. Liu, Q. Li, L. Chen
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
*Purpose: Recurrent focal segmental glomerulosclerosis(FSGS) is common after kidney transplantation . We conducted a retrospective cohort study with the aim to investigating the risk factors…
2020 American Transplant Congress
Outcomes of Acute Allograft Rejection Treatment with R Anti-Thymocyte Globulin (r-ATG) One Year Post Kidney Transplant
M. Yaqub, A. Riaz, D. Mishler, O. Adebiyi, T. Taber, A. Sharfuddin
Indiana University School of Medicine, Indianapolis, IN
*Purpose: Acute allograft rejection is considered one of the major causes of renal allograft dysfunction. Despite maximal anti-rejection therapy grafts may not regain baseline function.…
2020 American Transplant Congress
Hyperspectral Imaging of Human Kidney Allografts
R. Sucher¹, H. Köhler², A. Lederer¹, H. M. Hau¹, I. Gockel¹, D. Seehofer¹
¹Department of Visceral, Transplant-, Thoracic and Vascular Surgery, University Clinic Leipzig, Leipzig, Germany, ²Innovation Center for Computer Assisted Surgery, University Clinic Leipzig, Leipzig, Germany
*Purpose: Hyperspectral imaging (HSI) is capable to deliver non-contact, non-ionizing and non-invasive quantitative diagnostic information about tissue pathology, morphology and composition, based on the spectral…
2020 American Transplant Congress
Prevalence of Kidney Transplant-Associated Thrombotic Microangiopathy after ABO-Incompatible Kidney Transplantation
Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Thrombotic microangiopathy (TMA) is a dangerous disorder characterized by fragmented red blood cells, decreased platelet count, and organ failure due to thrombosis. We investigated…
2020 American Transplant Congress
Hepatologist and Surgeon Experiences Counseling Liver Transplant Candidates for an Organ Offer Decision
C. Schaffhausen¹, M. Bruin², S. Chu³, S. Chinnakotla⁴, J. R. Lake⁵, A. K. Israni⁶
¹Hennepin Heathcare Research Institute (HHRI), Minneapolis, MN, ²College of Design, University of Minnesota (UMN), Minneapolis, MN, ³College of Design, UMN, Minneapolis, MN, ⁴Department of Surgery, UMN, Minneapolis, MN, ⁵Division of Gastroenterology, Hepatology, and Nutrition, UMN, Minneapolis, MN, ⁶Department of Medicine, Hennepin Healthcare, UMN, Minneapolis, MN
*Purpose: Liver transplant candidates receive counseling during evaluations to understand donor risk factors. After long periods on the waitlist, candidates who receive an offer for…